Stage 1: Newly Admitted (<90d)·Healthcare & Pharma · Mumbai Bench 3·CIN: U24230MH2016PTC281904

Zenith Bio-Nutraceuticals Pvt Ltd

NCLT Case Number: CP(IB)/488/MB/2026

ACTIVE CIRP

Total Admitted Claims₹85.00 CrCategory: 50-100Cr

CIRP Age & Statutory CapDay 49/330Within 180d Limit

Mandate AngleInterim Finance & Early MandatesAdmission: 20 Aug 2026

Resolution ProfessionalMahesh Kumar Bagla, IRPirp.zenithbio@gmail.com

Litigation & Statutory Case Summary

Admitted on petition filed by Tata Capital under Section 7. Interim Resolution Professional taking custody of manufacturing unit in Thane. CoC formation underway. High potential for interim working capital finance.

Court Filing Repository (Cloudflare R2):Download Admission PDF

Statutory Audit Trail & Case Evolution

CIRP Admission Order2026-08-20

NCLT Mumbai Bench 3 admitted Section 7 application.

Public Announcement Form A2026-09-02

IRP invited claims from financial and operational creditors.

Alpha Score™ Rating

Founder's Office Proprietary

Early CIRP admission (Day 49). US-FDA compliant cleanroom packaging facility with minimal creditor friction.

Asset Quality91/100

Legal Friction92/100

Turnaround84/100

Full Intelligence Breakdown

Unlock lender haircut expectations, order backlog analysis & litigation risk assessment.

Founder's Office & Co Desk

Targeting this corporate debtor for resolution plan submission, bilateral ARC acquisition, or interim finance? Obtain valuation audits and lender representation directly from our desk.

Lead Intake: k@foundersoffice.co